IBIS Therapeutics Company

IBIS Therapeutics is accelerating drug discovery through Molecular Fingerprint™ Platform


Investors

Headquarters: Tampa, Florida, United States
Funding Status: Seed
Employee Number: 1-10
Last Funding Type: Seed
Last Funding Date: 2020-08-04
Investors Number: 1.0
Founded Date: 2017-01-01
Industry: Early Drug Development